Dysregulation of miRNAs in AL amyloidosis

Liangping Weng1, Brian H Spencer, Pamela T SoohHoo

  • 1Amyloid Treatment and Research Program, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA.

Insights

MicroRNAs (miRNAs) are dysregulated in immunoglobulin light chain (AL) amyloidosis. Specifically, miR-16 levels are elevated in patients with AL amyloidosis, suggesting potential use as disease biomarkers.

Area of Science:

  • Hematology
  • Molecular Biology
  • Genetics

Background:

  • Immunoglobulin light chain (AL) amyloidosis is a plasma cell disorder.
  • MicroRNAs (miRNAs) play crucial roles in cellular processes and disease pathogenesis.
  • Dysregulation of miRNAs in bone marrow plasma cells (BMPCs) is implicated in various hematologic malignancies.

Purpose of the Study:

  • To investigate miRNA expression profiles in BMPCs from patients with AL amyloidosis.
  • To identify specific miRNAs that are differentially expressed in AL amyloidosis compared to controls.
  • To explore the potential of these miRNAs as diagnostic or prognostic biomarkers for AL amyloidosis.

Main Methods:

  • Purification of BMPCs from AL amyloidosis patients and controls using anti-CD138 immunomagnetic beads.
  • Microarray analysis to compare miRNA expression levels.
  • Validation of key miRNA candidates using stem-loop RT-qPCR.

Main Results:

  • Ten miRNAs were found to be upregulated more than 1.5-fold in AL amyloidosis BMPCs.
  • miR-16 was significantly increased in AL amyloidosis patients at diagnosis and in those with persistent disease, but not in remission.
  • Expression of miR-15b was higher than miR-15a, suggesting miR-16 is mainly derived from the miR-16-2/miR-15b cluster.
  • The anti-apoptosis gene BCL-2 was expressed in AL amyloidosis BMPCs despite elevated miR-16 levels.

Conclusions:

  • miRNAs are dysregulated in clonal plasma cells in AL amyloidosis.
  • Specific miRNAs, such as miR-16, show altered expression patterns correlating with disease status.
  • These dysregulated miRNAs may serve as potential biomarkers for AL amyloidosis.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...